2Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update[J]. Dig Dis Sci, 2010, 55(3): 560-578.
3Chen W, Chang B, Li L, et al. Patatin-like phospholipase domain- containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease[J]. Hepatology, 2010, 52(3): 1134-1142.
4Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease[J]. Nat Genet, 2008, 40(12): 1461-1465.
5Qiao A, Liang J, Ke Y, et al. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis[J]. Hepatology, 2011, 54(2): 509-521.
6He S, McPhaul C, Li JZ, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis[J]. J Biol Chem, 2010, 285(9): 6706-6715.
7Li JZ, Huang Y, Karaman R, et al. Chronic overexpression of PNPLA31148M in mouse liver causes hepatic steatosis[J]. J Clin Invest, 2012, 122(11): 4130-4144.
8Xin YN, Zhao Y, Lin ZH, et al. Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity[J]. Proteins, 2013, 81(3): 406-414.
9Qiao L, Wu Q, Lu X, et al. SREBP-la activation by HBx and the effect on hepatitis B virus enhancer Ⅱ/core promoter[J]. Biochem Biophys Res Commun, 2013, 432(4): 643-649.
10Hao Q, Hansen JB, Petersen RK, et al. ADD1/SREBPlc activates the PGC 1-alpha promoter in brown adipocytes[J]. Biochim Biophys Acta, 2010, 1801(4): 421-429.
6Steven E. R. Hovius,Hester J. Kan,Xander Smit,Ruud Wf Selles,Eufimiano Cardoso,Roger K. Khouri,李可竹(译),郭澍(译),孙强(译),魏峰(译),高景恒(译).广泛经皮针刀筋膜切断术联合脂肪移植术：一种治疗掌腱膜挛缩的新疗法[J].中国美容整形外科杂志,2013,24(1). 被引量：2
